SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-17-007774
Filing Date
2017-04-28
Accepted
2017-04-28 16:30:17
Documents
5
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A sbph-defa14a_20170615.htm DEFA14A 39908
2 GRAPHIC g201704281357133312498.jpg GRAPHIC 8944
3 GRAPHIC g201704281357132972496.jpg GRAPHIC 76931
4 GRAPHIC g201704281357133192497.jpg GRAPHIC 16815
5 GRAPHIC g201704281357132822495.jpg GRAPHIC 47675
  Complete submission text file 0001564590-17-007774.txt   248559
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37718 | Film No.: 17796049
SIC: 2834 Pharmaceutical Preparations